Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1998 Mar 16;17(6):1588–1597. doi: 10.1093/emboj/17.6.1588

Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.

A van der Spoel 1, E Bonten 1, A d'Azzo 1
PMCID: PMC1170506  PMID: 9501080

Abstract

Human lysosomal N-acetyl-alpha-neuraminidase is deficient in two lysosomal storage disorders, sialidosis, caused by structural mutations in the neuraminidase gene, and galactosialidosis, in which a primary defect of protective protein/cathepsin A (PPCA) leads to a combined deficiency of neuraminidase and beta-D-galactosidase. These three glycoproteins can be isolated in a high molecular weight multi-enzyme complex, and the enzymatic activity of neuraminidase is contingent on its interaction with PPCA. To explain the unusual need of neuraminidase for an auxiliary protein, we examined, in transfected COS-1 cells, the effect of PPCA expression on post-translational modification, turnover and intracellular localization of neuraminidase. In pulse-chase studies, we show that the enzyme is synthesized as a 46 kDa glycoprotein, which is poorly phosphorylated, does not undergo major proteolytic processing and is secreted. Importantly, its half-life is not altered by the presence of PPCA. However, neuraminidase associates with the PPCA precursor shortly after synthesis, since the latter protein co-precipitates with neuraminidase using anti-neuraminidase antibodies. We further demonstrate by subcellular fractionation of transfected cells that neuraminidase segregates to mature lysosomes only when accompanied by wild-type PPCA, but not by transport-impaired PPCA mutants. These data suggest a novel role for PPCA in the activation of lysosomal neuraminidase, that of an intracellular transport protein.

Full Text

The Full Text of this article is available as a PDF (406.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amigorena S., Drake J. R., Webster P., Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature. 1994 May 12;369(6476):113–120. doi: 10.1038/369113a0. [DOI] [PubMed] [Google Scholar]
  2. Bonten E. J., Galjart N. J., Willemsen R., Usmany M., Vlak J. M., d'Azzo A. Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation. J Biol Chem. 1995 Nov 3;270(44):26441–26445. doi: 10.1074/jbc.270.44.26441. [DOI] [PubMed] [Google Scholar]
  3. Bonten E., van der Spoel A., Fornerod M., Grosveld G., d'Azzo A. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 1996 Dec 15;10(24):3156–3169. doi: 10.1101/gad.10.24.3156. [DOI] [PubMed] [Google Scholar]
  4. Burmeister W. P., Ruigrok R. W., Cusack S. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J. 1992 Jan;11(1):49–56. doi: 10.1002/j.1460-2075.1992.tb05026.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987 Aug;7(8):2745–2752. doi: 10.1128/mcb.7.8.2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Corfield T. Bacterial sialidases--roles in pathogenicity and nutrition. Glycobiology. 1992 Dec;2(6):509–521. doi: 10.1093/glycob/2.6.509. [DOI] [PubMed] [Google Scholar]
  7. D'Agrosa R. M., Callahan J. W. In vitro activation of neuraminidase in the beta-galactosidase-neuraminidase-protective protein complex by cathepsin C. Biochem Biophys Res Commun. 1988 Dec 15;157(2):770–775. doi: 10.1016/s0006-291x(88)80316-4. [DOI] [PubMed] [Google Scholar]
  8. D'Azzo A., Hoogeveen A., Reuser A. J., Robinson D., Galjaard H. Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4535–4539. doi: 10.1073/pnas.79.15.4535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fornerod M., Boer J., van Baal S., Jaeglé M., von Lindern M., Murti K. G., Davis D., Bonten J., Buijs A., Grosveld G. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene. 1995 May 4;10(9):1739–1748. [PubMed] [Google Scholar]
  10. Galjart N. J., Gillemans N., Harris A., van der Horst G. T., Verheijen F. W., Galjaard H., d'Azzo A. Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell. 1988 Sep 9;54(6):755–764. doi: 10.1016/s0092-8674(88)90999-3. [DOI] [PubMed] [Google Scholar]
  11. Galjart N. J., Morreau H., Willemsen R., Gillemans N., Bonten E. J., d'Azzo A. Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J Biol Chem. 1991 Aug 5;266(22):14754–14762. [PubMed] [Google Scholar]
  12. Gieselmann V., Pohlmann R., Hasilik A., Von Figura K. Biosynthesis and transport of cathepsin D in cultured human fibroblasts. J Cell Biol. 1983 Jul;97(1):1–5. doi: 10.1083/jcb.97.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Glombitza G. J., Becker E., Kaiser H. W., Sandhoff K. Biosynthesis, processing, and intracellular transport of GM2 activator protein in human epidermal keratinocytes. The lysosomal targeting of the GM2 activator is independent of a mannose-6-phosphate signal. J Biol Chem. 1997 Feb 21;272(8):5199–5207. doi: 10.1074/jbc.272.8.5199. [DOI] [PubMed] [Google Scholar]
  14. Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell. 1981 Jan;23(1):175–182. doi: 10.1016/0092-8674(81)90282-8. [DOI] [PubMed] [Google Scholar]
  15. Hasilik A. The early and late processing of lysosomal enzymes: proteolysis and compartmentation. Experientia. 1992 Feb 15;48(2):130–151. doi: 10.1007/BF01923507. [DOI] [PubMed] [Google Scholar]
  16. Hille-Rehfeld A. Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes. Biochim Biophys Acta. 1995 Jul 17;1241(2):177–194. doi: 10.1016/0304-4157(95)00004-b. [DOI] [PubMed] [Google Scholar]
  17. Hiraiwa M., Yamauchi T., Tsuji S., Nishizawa M., Miyatake T., Oyanagi K., Ikuta F., Uda Y. Activation of human lysosomal sialidase. J Biochem. 1993 Dec;114(6):901–905. doi: 10.1093/oxfordjournals.jbchem.a124274. [DOI] [PubMed] [Google Scholar]
  18. Hogue B. G., Nayak D. P. Synthesis and processing of the influenza virus neuraminidase, a type II transmembrane glycoprotein. Virology. 1992 Jun;188(2):510–517. doi: 10.1016/0042-6822(92)90505-j. [DOI] [PubMed] [Google Scholar]
  19. Hunziker W., Geuze H. J. Intracellular trafficking of lysosomal membrane proteins. Bioessays. 1996 May;18(5):379–389. doi: 10.1002/bies.950180508. [DOI] [PubMed] [Google Scholar]
  20. Isidoro C., Grässel S., Baccino F. M., Hasilik A. Determination of the phosphorylation, uncovering of mannose 6-phosphate groups and targeting of lysosomal enzymes. Eur J Clin Chem Clin Biochem. 1991 Mar;29(3):165–171. doi: 10.1515/cclm.1991.29.3.165. [DOI] [PubMed] [Google Scholar]
  21. Kleijer W. J., Geilen G. C., Janse H. C., van Diggelen O. P., Zhou X. Y., Galjart N. J., Galjaard H., d'Azzo A. Cathepsin A deficiency in galactosialidosis: studies of patients and carriers in 16 families. Pediatr Res. 1996 Jun;39(6):1067–1071. doi: 10.1203/00006450-199606000-00022. [DOI] [PubMed] [Google Scholar]
  22. Milner C. M., Smith S. V., Carrillo M. B., Taylor G. L., Hollinshead M., Campbell R. D. Identification of a sialidase encoded in the human major histocompatibility complex. J Biol Chem. 1997 Feb 14;272(7):4549–4558. doi: 10.1074/jbc.272.7.4549. [DOI] [PubMed] [Google Scholar]
  23. Morreau H., Galjart N. J., Gillemans N., Willemsen R., van der Horst G. T., d'Azzo A. Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J Biol Chem. 1989 Dec 5;264(34):20655–20663. [PubMed] [Google Scholar]
  24. Morreau H., Galjart N. J., Willemsen R., Gillemans N., Zhou X. Y., d'Azzo A. Human lysosomal protective protein. Glycosylation, intracellular transport, and association with beta-galactosidase in the endoplasmic reticulum. J Biol Chem. 1992 Sep 5;267(25):17949–17956. [PubMed] [Google Scholar]
  25. Pisoni R. L., Flickinger K. S., Thoene J. G., Christensen H. N. Characterization of carrier-mediated transport systems for small neutral amino acids in human fibroblast lysosomes. J Biol Chem. 1987 May 5;262(13):6010–6017. [PubMed] [Google Scholar]
  26. Proia R. L., d'Azzo A., Neufeld E. F. Association of alpha- and beta-subunits during the biosynthesis of beta-hexosaminidase in cultured human fibroblasts. J Biol Chem. 1984 Mar 10;259(5):3350–3354. [PubMed] [Google Scholar]
  27. Pshezhetsky A. V., Potier M. Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate. J Biol Chem. 1996 Nov 8;271(45):28359–28365. doi: 10.1074/jbc.271.45.28359. [DOI] [PubMed] [Google Scholar]
  28. Pshezhetsky A. V., Potier M. Direct affinity purification and supramolecular organization of human lysosomal cathepsin A. Arch Biochem Biophys. 1994 Aug 15;313(1):64–70. doi: 10.1006/abbi.1994.1359. [DOI] [PubMed] [Google Scholar]
  29. Pshezhetsky A. V., Richard C., Michaud L., Igdoura S., Wang S., Elsliger M. A., Qu J., Leclerc D., Gravel R., Dallaire L. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet. 1997 Mar;15(3):316–320. doi: 10.1038/ng0397-316. [DOI] [PubMed] [Google Scholar]
  30. Reuter G., Gabius H. J. Sialic acids structure-analysis-metabolism-occurrence-recognition. Biol Chem Hoppe Seyler. 1996 Jun;377(6):325–342. doi: 10.1515/bchm3.1996.377.6.325. [DOI] [PubMed] [Google Scholar]
  31. Rijnboutt S., Aerts H. M., Geuze H. J., Tager J. M., Strous G. J. Mannose 6-phosphate-independent membrane association of cathepsin D, glucocerebrosidase, and sphingolipid-activating protein in HepG2 cells. J Biol Chem. 1991 Mar 15;266(8):4862–4868. [PubMed] [Google Scholar]
  32. Rijnboutt S., Kal A. J., Geuze H. J., Aerts H., Strous G. J. Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells. J Biol Chem. 1991 Dec 15;266(35):23586–23592. [PubMed] [Google Scholar]
  33. Roggentin P., Schauer R., Hoyer L. L., Vimr E. R. The sialidase superfamily and its spread by horizontal gene transfer. Mol Microbiol. 1993 Sep;9(5):915–921. doi: 10.1111/j.1365-2958.1993.tb01221.x. [DOI] [PubMed] [Google Scholar]
  34. Saito T., Taylor G., Webster R. G. Steps in maturation of influenza A virus neuraminidase. J Virol. 1995 Aug;69(8):5011–5017. doi: 10.1128/jvi.69.8.5011-5017.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shimmoto M., Fukuhara Y., Itoh K., Oshima A., Sakuraba H., Suzuki Y. Protective protein gene mutations in galactosialidosis. J Clin Invest. 1993 Jun;91(6):2393–2398. doi: 10.1172/JCI116472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tikkanen R., Enomaa N., Riikonen A., Ikonen E., Peltonen L. Intracellular sorting of aspartylglucosaminidase: the role of N-linked oligosaccharides and evidence of Man-6-P-independent lysosomal targeting. DNA Cell Biol. 1995 Apr;14(4):305–312. doi: 10.1089/dna.1995.14.305. [DOI] [PubMed] [Google Scholar]
  37. Tulp A., Verwoerd D., Pieters J. Application of an improved density gradient electrophoresis apparatus to the separation of proteins, cells and subcellular organelles. Electrophoresis. 1993 Dec;14(12):1295–1301. doi: 10.1002/elps.11501401198. [DOI] [PubMed] [Google Scholar]
  38. Verheijen F. W., Palmeri S., Hoogeveen A. T., Galjaard H. Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein. Eur J Biochem. 1985 Jun 3;149(2):315–321. doi: 10.1111/j.1432-1033.1985.tb08928.x. [DOI] [PubMed] [Google Scholar]
  39. Vielhaber G., Hurwitz R., Sandhoff K. Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP )precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP precursor. J Biol Chem. 1996 Dec 13;271(50):32438–32446. doi: 10.1074/jbc.271.50.32438. [DOI] [PubMed] [Google Scholar]
  40. Vincent R., Nadeau D. Adjustment of the osmolality of Percoll for the isopycnic separation of cells and cell organelles. Anal Biochem. 1984 Sep;141(2):322–328. doi: 10.1016/0003-2697(84)90049-6. [DOI] [PubMed] [Google Scholar]
  41. Wolf P. R., Ploegh H. L. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol. 1995;11:267–306. doi: 10.1146/annurev.cb.11.110195.001411. [DOI] [PubMed] [Google Scholar]
  42. Yamamoto Y., Nishimura K. Copurification and separation of beta-galactosidase and sialidase from porcine testis. Int J Biochem. 1987;19(5):435–442. doi: 10.1016/0020-711x(87)90064-4. [DOI] [PubMed] [Google Scholar]
  43. Zhou X. Y., Galjart N. J., Willemsen R., Gillemans N., Galjaard H., d'Azzo A. A mutation in a mild form of galactosialidosis impairs dimerization of the protective protein and renders it unstable. EMBO J. 1991 Dec;10(13):4041–4048. doi: 10.1002/j.1460-2075.1991.tb04980.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zhou X. Y., Morreau H., Rottier R., Davis D., Bonten E., Gillemans N., Wenger D., Grosveld F. G., Doherty P., Suzuki K. Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev. 1995 Nov 1;9(21):2623–2634. doi: 10.1101/gad.9.21.2623. [DOI] [PubMed] [Google Scholar]
  45. Zhou X. Y., van der Spoel A., Rottier R., Hale G., Willemsen R., Berry G. T., Strisciuglio P., Morrone A., Zammarchi E., Andria G. Molecular and biochemical analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosis. Hum Mol Genet. 1996 Dec;5(12):1977–1987. doi: 10.1093/hmg/5.12.1977. [DOI] [PubMed] [Google Scholar]
  46. d'Azzo A., Proia R. L., Kolodny E. H., Kaback M. M., Neufeld E. F. Faulty association of alpha- and beta-subunits in some forms of beta-hexosaminidase A deficiency. J Biol Chem. 1984 Sep 10;259(17):11070–11074. [PubMed] [Google Scholar]
  47. van Diggelen O. P., Hoogeveen A. T., Smith P. J., Reuser A. J., Galjaard H. Enhanced proteolytic degradation of normal beta-galactosidase in the lysosomal storage disease with combined beta-galactosidase and neuraminidase deficiency. Biochim Biophys Acta. 1982 Apr 21;703(1):69–76. doi: 10.1016/0167-4838(82)90012-7. [DOI] [PubMed] [Google Scholar]
  48. van Dongen J. M., Willemsen R., Ginns E. I., Sips H. J., Tager J. M., Barranger J. A., Reuser A. J. The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study. Eur J Cell Biol. 1985 Nov;39(1):179–189. [PubMed] [Google Scholar]
  49. von Figura K., Hasilik A. Lysosomal enzymes and their receptors. Annu Rev Biochem. 1986;55:167–193. doi: 10.1146/annurev.bi.55.070186.001123. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES